-
Here's What To Expect Following Trump's Drug Pricing 'Robbery' Comments
Tuesday, January 17, 2017 - 12:33pm | 345Perhaps the only thing that traders can know for certain about President-elect Donald Trump’s policy decisions is that they should always expect the unexpected. Biotech investors thought they had scored a major victory in November when Trump defeated Hillary Clinton. Clinton had made...
-
Citron Research Renews Attack On Express Scripts
Wednesday, December 14, 2016 - 1:23pm | 342Shares of Express Scripts Holding Company (NASDAQ: ESRX) fell more than 6 percent on Wednesday after the company announced its 2017 financial guidance and hosted a conference call to discuss its outlook. Citron On The Offense Notable short seller Citron Research likened Express Scripts last week as...
-
What If Trump Keeps Badmouthing Drug Pricing?
Wednesday, December 7, 2016 - 2:38pm | 400Pharmaceutical companies breathed a sigh of relief when Donald Trump prevailed on Election Day. His opponent, Hillary Clinton, had made prescription drug pricing a centerpiece of her campaign. However, according to Bernstein analyst Tim Anderson, pharma stocks may not be off the hook when Trump...
-
How Healthcare ETFs Shaped Up Ahead Of Election Day
Tuesday, November 8, 2016 - 4:11pm | 487It is the second-largest sector weight in the S&P 500 and also the worst-performing corner of the benchmark U.S. equity gauge this year, but with Election Day finally here, it is possible the worst is behind the healthcare space. The Health Care SPDR (ETF) (NYSE: XLV), the largest healthcare...
-
Walgreens-Rite Aid Buyout Will 'Hopefully' Put Downward Pressure On Drug Prices
Wednesday, October 28, 2015 - 12:29pm | 512Two of the nation's largest drugstore companies are coming together. Walgreens Boots Alliance Inc (NASDAQ: WBA) on Tuesday agreed to purchase Rite Aid Corporation (NYSE: RAD) for a little over $9 billion, or about $9 per share in cash. Rite Aid shares soared 40 percent when The Wall Street...